Antacids Market

Antacids Market Study by Proton Pump Inhibitors, H2 Antagonists, and Acid Neutralizers for Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies from 2023 to 2033

Analysis of Antacids Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Table of Content

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunity

    4.4. Global Market Value (US$ Mn) Forecast, 2023 - 2033

    4.5. Porter’s Five Force Analysis

    4.6. Value Chain Analysis

    4.7. Market Outlook

5. Global Market Analysis and Forecasts, By Drug Class

    5.1. Introduction & Definition

    5.2. Key Findings / Developments

    5.3. Key Trends

    5.4. Market Value (US$ Mn) Forecast By Drug Class, 2023-2033

        5.4.1. Proton pump inhibitors

        5.4.2. H2 Antagonist

        5.4.3. Acid neutralizers

    5.5. Market Attractiveness By Drug Class

6. Global Market Analysis and Forecasts, By Formulation

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Key Trends

    6.4. Market Value (US$ Mn) Forecast By Formulation, 2023-2033

        6.4.1. Tablet

        6.4.2. Liquid

        6.4.3. Powder

        6.4.4. Others

    6.5. Market Attractiveness By Formulation

7. Global Market Analysis and Forecasts, By Distribution Channel

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Key Trends

    7.4. Market Value (US$ Mn) Forecast By Distribution Channel, 2023-2033

        7.4.1. Hospital Pharmacies

        7.4.2. Retail Pharmacies

        7.4.3. Others

    7.5. Market Attractiveness By Distribution Channel

8. Global Market Analysis and Forecasts, By Region

    8.1. Key Findings

    8.2. Market Value (US$ Mn) Forecast By Region

        8.2.1. North America

        8.2.2. Europe

        8.2.3. Asia Pacific

        8.2.4. Latin America

        8.2.5. Middle East and Africa

    8.3. Market Attractiveness By Country/Region

9. North America Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

        9.1.2. Key Trends

    9.2. Market Value (US$ Mn) Forecast By Drug Class, 2023-2033

        9.2.1. Proton pump inhibitors

        9.2.2. H2 Antagonist

        9.2.3. Acid neutralizers

    9.3. Market Value (US$ Mn) Forecast By Formulation, 2023-2033

        9.3.1. Tablet

        9.3.2. Liquid

        9.3.3. Powder

        9.3.4. Others

    9.4. Market Value (US$ Mn) Forecast By Distribution Channel, 2023-2033

        9.4.1. Hospital Pharmacies

        9.4.2. Retail Pharmacies

        9.4.3. Others

    9.5. Market Value (US$ Mn) Forecast By Country, 2023-2033

        9.5.1. U.S.

        9.5.2. Canada

    9.6. Market Attractiveness Analysis

        9.6.1. By Drug Class

        9.6.2. By Formulation

        9.6.3. By Distribution Channel

        9.6.4. By Country

10. Europe Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

        10.1.2. Key Trends

    10.2. Market Value (US$ Mn) Forecast By Drug Class, 2023-2033

        10.2.1. Proton pump inhibitors

        10.2.2. H2 Antagonist

        10.2.3. Acid neutralizers

    10.3. Market Value (US$ Mn) Forecast By Formulation, 2023-2033

        10.3.1. Tablet

        10.3.2. Liquid

        10.3.3. Powder

        10.3.4. Others

    10.4. Market Value (US$ Mn) Forecast By Distribution Channel, 2023-2033

        10.4.1. Hospital Pharmacies

        10.4.2. Retail Pharmacies

        10.4.3. Others

    10.5. Market Value (US$ Mn) Forecast By Country, 2023-2033

        10.5.1. U.K.

        10.5.2. Germany

        10.5.3. France

        10.5.4. Spain

        10.5.5. Italy

        10.5.6. Rest of Europe

    10.6. Market Attractiveness Analysis

        10.6.1. By Drug Class

        10.6.2. By Formulation

        10.6.3. By Distribution Channel

        10.6.4. By Country

11. Asia Pacific Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

        11.1.2. Key Trends

    11.2. Market Value (US$ Mn) Forecast By Drug Class, 2023-2033

        11.2.1. Proton pump inhibitors

        11.2.2. H2 Antagonist

        11.2.3. Acid neutralizers

    11.3. Market Value (US$ Mn) Forecast By Formulation, 2023-2033

        11.3.1. Tablet

        11.3.2. Liquid

        11.3.3. Powder

        11.3.4. Others

    11.4. Market Value (US$ Mn) Forecast By Distribution Channel, 2023-2033

        11.4.1. Hospital Pharmacies

        11.4.2. Retail Pharmacies

        11.4.3. Others

    11.5. Market Value (US$ Mn) Forecast By Country, 2023-2033

        11.5.1. India

        11.5.2. China

        11.5.3. Japan

        11.5.4. Australia & New Zealand

        11.5.5. Rest of Aisa Pacific

    11.6. Market Attractiveness Analysis

        11.6.1. By Drug Class

        11.6.2. By Formulation

        11.6.3. By Distribution Channel

        11.6.4. By Country

12. Latin America Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

        12.1.2. Key Trends

    12.2. Market Value (US$ Mn) Forecast By Drug Class, 2023-2033

        12.2.1. Proton pump inhibitors

        12.2.2. H2 Antagonist

        12.2.3. Acid neutralizers

    12.3. Market Value (US$ Mn) Forecast By Formulation, 2023-2033

        12.3.1. Tablet

        12.3.2. Liquid

        12.3.3. Powder

        12.3.4. Others

    12.4. Market Value (US$ Mn) Forecast By Distribution Channel, 2023-2033

        12.4.1. Hospital Pharmacies

        12.4.2. Retail Pharmacies

        12.4.3. Others

    12.5. Market Value (US$ Mn) Forecast By Country, 2023-2033

        12.5.1. Brazil

        12.5.2. Mexico

        12.5.3. Rest of Latin America

    12.6. Market Attractiveness Analysis

        12.6.1. By Drug Class

        12.6.2. By Formulation

        12.6.3. By Distribution Channel

        12.6.4. By Country

13. Middle East and Africa Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

        13.1.2. Key Trends

    13.2. Market Value (US$ Mn) Forecast By Drug Class, 2023-2033

        13.2.1. Proton pump inhibitors

        13.2.2. H2 Antagonist

        13.2.3. Acid neutralizers

    13.3. Market Value (US$ Mn) Forecast By Formulation, 2023-2033

        13.3.1. Tablet

        13.3.2. Liquid

        13.3.3. Powder

        13.3.4. Others

    13.4. Market Value (US$ Mn) Forecast By Distribution Channel, 2023-2033

        13.4.1. Hospital Pharmacies

        13.4.2. Retail Pharmacies

        13.4.3. Others

    13.5. Market Value (US$ Mn) Forecast By Country, 2023-2033

        13.5.1. South Africa

        13.5.2. Saudi Arabia

        13.5.3. Rest of MEA

    13.6. Market Attractiveness Analysis

        13.6.1. By Drug Class

        13.6.2. By Formulation

        13.6.3. By Distribution Channel

        13.6.4. By Country

14. Competition Landscape

    14.1. Market Players

    14.2. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)

        14.2.1. AstraZeneca

            14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.1.2. Business Overview

            14.2.1.3. Product Portfolio

            14.2.1.4. Financial Overview

            14.2.1.5. SWOT Analysis

            14.2.1.6. Strategic overview

        14.2.2. Bayer AG

            14.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.2.2. Business Overview

            14.2.2.3. Product Portfolio

            14.2.2.4. Financial Overview

            14.2.2.5. SWOT Analysis

            14.2.2.6. Strategic overview

        14.2.3. Boehringer Ingelheim GmbH

            14.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.3.2. Business Overview

            14.2.3.3. Product Portfolio

            14.2.3.4. Financial Overview

            14.2.3.5. SWOT Analysis

            14.2.3.6. Strategic overview

        14.2.4. Dr. Reddy’s Laboratories Ltd.

            14.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.4.2. Business Overview

            14.2.4.3. Product Portfolio

            14.2.4.4. Financial Overview

            14.2.4.5. SWOT Analysis

            14.2.4.6. Strategic overview

        14.2.5. GlaxoSmithKline plc

            14.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.5.2. Business Overview

            14.2.5.3. Product Portfolio

            14.2.5.4. Financial Overview

            14.2.5.5. SWOT Analysis

            14.2.5.6. Strategic overview

        14.2.6. Johnson & Johnson

            14.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.6.2. Business Overview

            14.2.6.3. Product Portfolio

            14.2.6.4. Financial Overview

            14.2.6.5. SWOT Analysis

            14.2.6.6. Strategic overview

        14.2.7. Pfizer Inc.

            14.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.7.2. Business Overview

            14.2.7.3. Product Portfolio

            14.2.7.4. Financial Overview

            14.2.7.5. SWOT Analysis

            14.2.7.6. Strategic overview

        14.2.8. Procter & Gamble

            14.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.8.2. Business Overview

            14.2.8.3. Product Portfolio

            14.2.8.4. Financial Overview

            14.2.8.5. SWOT Analysis

            14.2.8.6. Strategic overview

        14.2.9. Reckitt Benckiser Group plc

            14.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.9.2. Business Overview

            14.2.9.3. Product Portfolio

            14.2.9.4. Financial Overview

            14.2.9.5. SWOT Analysis

            14.2.9.6. Strategic overview

        14.2.10. Sanofi

            14.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.10.2. Business Overview

            14.2.10.3. Product Portfolio

            14.2.10.4. Financial Overview

            14.2.10.5. SWOT Analysis

            14.2.10.6. Strategic overview

        14.2.11. Sun Pharmaceuticals Ltd

            14.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.11.2. Business Overview

            14.2.11.3. Product Portfolio

            14.2.11.4. Financial Overview

            14.2.11.5. SWOT Analysis

            14.2.11.6. Strategic overview

        14.2.12. Takeda Pharmaceutical

            14.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.12.2. Business Overview

            14.2.12.3. Product Portfolio

            14.2.12.4. Financial Overview

            14.2.12.5. SWOT Analysis

            14.2.12.6. Strategic overview

        14.2.13. Valeant Pharmaceuticals International, Inc.

            14.2.13.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.13.2. Business Overview

            14.2.13.3. Product Portfolio

            14.2.13.4. Financial Overview

            14.2.13.5. SWOT Analysis

            14.2.13.6. Strategic overview

Don't Need a Global Report?

save 40%! on Country & Region specific reports

List Of Table

Table 01: Global Market Size (US$ Mn) Forecast, By Drug Class, 2018–2033

Table 02: Global Market Size (US$ Mn) Forecast, By Formulation, 2023-2033

Table 03: Global Market Size (US$ Mn) Forecast, By Distribution Channel, 2018–2033

Table 04: Global Market (US$ Mn) Forecast, By Region, 2018–2033

Table 05: North America Market Size (US$ Mn) Forecast, by Drug Class, 2018–2033

Table 06: North America Market Size (US$ Mn) Forecast, by Formulation, 2018–2033

Table 07: North America Market Size (US$ Mn) Forecast, By Distribution Channel, 2018–2033

Table 08: North America Market Size (US$ Mn) Forecast, by Country, 2018–2033

Table 09: Europe Market Size (US$ Mn) Forecast, by Drug Class, 2018–2033

Table 10: Europe Market Size (US$ Mn) Forecast, by Formulation, 2018–2033

Table 11: Europe Market Size (US$ Mn) Forecast, By Distribution Channel, 2018 and 2033

Table 12: Europe Market Size (US$ Mn) Forecast, by Country, 2018–2033

Table 13: Asia Pacific Market Size (US$ Mn) Forecast, by Drug Class, 2018–2033

Table 14: Asia Pacific Market Size (US$ Mn) Forecast, by Formulation, 2018–2033

Table 15: Asia Pacific Market Size (US$ Mn) Forecast, By Distribution Channel, 2018 and 2033

Table 16: Asia Pacific Market Size (US$ Mn) Forecast, by Country, 2018–2033

Table 17: Latin America Market Size (US$ Mn) Forecast, by Drug Class, 2018–2033

Table 18: Latin America Market Size (US$ Mn) Forecast, by Formulation, 2018–2033

Table 19: Latin America Market Size (US$ Mn) Forecast, By Distribution Channel, 2018–2033

Table 20: Latin America Market Size (US$ Mn) Forecast, by Country, 2018–2033

Table 21: Middle East and Africa Market Size (US$ Mn) Forecast, by Drug Class, 2018–2033

Table 22: Middle East and Africa Market Size (US$ Mn) Forecast, by Formulation, 2018–2033

Table 23: Middle East and Africa Market Size (US$ Mn) Forecast, By Distribution Channel, 2018 and 2033

Table 24: Middle East and Africa Market Size (US$ Mn) Forecast, by Country, 2018–2033

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

List Of Figures

Figure 01: Global Market Size (US$ Mn) Forecast, 2018–2033

Figure 02: Market Value Share, By Drug Class (2022)

Figure 03: Market Value Share, By Formulation (2022)

Figure 04: Market Value Share By, Distribution Channel (2022)

Figure 05: Market Value Share, By Region (2022)

Figure 06: Porter’s Five Force Analysis

Figure 07: Global Market Value Share Analysis, By Drug Class, 2022 and 2033

Figure 08: Global Proton Pump Inhibitor Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2033

Figure 09: Global H2 Antagonist Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2033

Figure 10: Global Acid Neutralizer Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2033

Figure 11: Market Attractiveness Analysis, By Drug Class

Figure 12: Global Market Value Share Analysis, By Formulation, 2022 and 2033

Figure 13: Global Tablet Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2033

Figure 14: Global Liquids Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2033

Figure 15: Global Powder Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2033

Figure 16: Global Others Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2033

Figure 17: Global Market Attractiveness Analysis, By Formulation

Figure 18: Global Market Value Share Analysis, By Distribution Channel, 2022 and 2033

Figure 19: Global Hospital Pharmacies Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2033

Figure 20: Global Retail Pharmacies Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2033

Figure 21: Global Others Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2033

Figure 22: Global Market Attractiveness Analysis, By Distribution Channel

Figure 23: Global Market Value Share, By Region, 2022 and 2033

Figure 24: Global Market Attractiveness Analysis, By Region Type

Figure 25: North America Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2018–2033

Figure 26: North America Market Attractiveness Analysis, By Country

Figure 27: North America Market Value Share Analysis, By Drug Class, 2022 and 2033

Figure 28: North America Market Value Share Analysis, By Formulation, 2022 and 2033

Figure 29: North America Market Value Share Analysis, By Distribution Channel, 2022 and 2033

Figure 30: North America Market Value Share Analysis, By Country, 2022 and 2033

Figure 31: North America Market Attractiveness Analysis, By Drug Class

Figure 32: North America Market Attractiveness Analysis, By Formulation

Figure 33: North America Market Attractiveness Analysis, By Distribution Channel

Figure 34: Europe Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2018–2033

Figure 35: Europe Market Attractiveness Analysis, By Country

Figure 36: Europe Market Value Share Analysis, By Drug Class, 2022 and 2033

Figure 37: Europe Market Value Share Analysis, By Formulation, 2022 and 2033

Figure 38: Europe Market Value Share Analysis, By Distribution Channel, 2022 and 2033

Figure 39: Europe Market Value Share Analysis, By Country, 2022 and 2033

Figure 40: Europe Market Attractiveness Analysis, By Drug Class

Figure 41: Europe Market Attractiveness Analysis, By Formulation

Figure 42: Europe Market Attractiveness Analysis, By Distribution Channel

Figure 43: Asia Pacific Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2018–2033

Figure 44: Asia Pacific Market Attractiveness Analysis, By Country

Figure 45: Asia Pacific Market Value Share Analysis, By Drug Class, 2022 and 2033

Figure 46: Asia Pacific Market Value Share Analysis, By Formulation, 2022 and 2033

Figure 47: Asia Pacific Market Value Share Analysis, By Distribution Channel, 2022 and 2033

Figure 48: Asia Pacific Market Value Share Analysis, By Country, 2022 and 2033

Figure 49: Asia Pacific Market Attractiveness Analysis, By Drug Class

Figure 50: Asia Pacific Market Attractiveness Analysis, By Formulation

Figure 51: Asia Pacific Market Attractiveness Analysis, By Distribution Channel

Figure 52: Latin America Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2018–2033

Figure 53: Latin America Market Attractiveness Analysis, By Country

Figure 54: Latin America Market Value Share Analysis, By Drug Class, 2022 and 2033

Figure 55: Latin America Market Value Share Analysis, By Formulation, 2022 and 2033

Figure 56: Latin America Market Value Share Analysis, By Distribution Channel, 2022 and 2033

Figure 57: Latin America Market Value Share Analysis, By Country, 2022 and 2033

Figure 58: Latin America Market Attractiveness Analysis, By Drug Class

Figure 59: Latin America Market Attractiveness Analysis, By Formulation

Figure 60: Latin America Market Attractiveness Analysis, By Distribution Channel

Figure 61: Middle East and Africa Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2018–2033

Figure 62: Middle East and Africa Market Attractiveness Analysis, By Country

Figure 63: Middle East and Africa Market Value Share Analysis, By Drug Class, 2022 and 2033

Figure 64: Middle East and Africa Market Value Share Analysis, By Formulation, 2022 and 2033

Figure 65: Middle East and Africa Market Value Share Analysis, By Distribution Channel, 2022 and 2033

Figure 66: Middle East and Africa Market Value Share Analysis, By Country, 2022 and 2033

Figure 67: Middle East and Africa Market Attractiveness Analysis, By Drug Class

Figure 68: Middle East and Africa Market Attractiveness Analysis, By Formulation

Figure 69: Middle East and Africa Market Attractiveness Analysis, By Distribution Channel

Figure 70: AstraZeneca, Breakdown of Net Sales (%), by Region, 2022

Figure 71: AstraZeneca, Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2022

Figure 72: Bayer AG, Breakdown of Net Sales (%), by Region, 2022

Figure 73: Bayer AG, Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2022

Figure 74: Boehringer Ingelheim, Break down of Net Sales (%), by Region, 2022

Figure 75: Boehringer Ingelheim, Revenue (US$ Mn) & Y-o-Y Growth (%), 2018–2022

Figure 76: Dr. Reddy’s, Breakdown of Net Sales (%), by Region, 2022

Figure 77: Dr. Reddy’s, Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2022

Figure 78: GlaxoSmithKline, Breakdown of Net Sales (%), by Region, 2022

Figure 79: GlaxoSmithKline, Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2022

Figure 80: Johnson & Johnson, Break down of Net Sales (%), by Region, 2022

Figure 81: Johnson & Johnson, Revenue (US$ Mn) and Y-o-Y Growth (%), 2018-2022

Figure 82: Pfizer Inc., Breakdown of Net Sales (%), by Region, 2022 (%)

Figure 83: Pfizer Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2022

Figure 84: P&G, Breakdown of Net Sales (%), by Region, 2022

Figure 85: P&G, Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2022

Figure 86: Reckitt Benckiser, Breakdown of Net Sales (%), by Region, 2022

Figure 87: Reckitt Benckiser, Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2022

Figure 88: Sanofi, Breakdown of Net Sales (%), by Region, 2022

Figure 89: Sanofi, Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2022

Figure 90: Breakdown of Net Sales (%), by Region, 2022

Figure 91: Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2022

Figure 92: Takeda Pharmaceutical, Break down of Net Sales (%), by Region, 2022

Figure 93: Takeda Pharmaceutical, Revenue (US$ Bn) & Y-o-Y Growth (%), 2018–2022

Figure 94: Valeant Pharmaceuticals International, Inc., Break down of Net Sales (%), by Region, 2022

Figure 95: Valeant Pharmaceuticals International, Inc., Revenue (US$ Bn) & Y-o-Y Growth (%), 2018–2022

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Antacids Market

Schedule a Call